?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
518 Unternehmen gefunden • Seite 2 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hansoh Pharmaceutical Group Co Ltd | 79.0 | Arzneimittel (Pharmazeutisch) | China | 25.3 Mrd. USD | 25.41 | 45.01 | 10.68 | 4.49 | ▲ 11.58% | ▲ 16.68% | 1.32% | - | - | 36.97% | ▲ 2.74% | 36.04% | ▲ 0.90% | 41.58% | ▲ 4.39% | 6 / 9 | 15,76 | > 50-fach | 34 / 100 | −3,0 / 100 | −2,69 | |
![]() | Exelixis Inc | 78.8 | Arzneimittel (Biotechnologie) | USA | 13.9 Mrd. USD | 16.16 | 11.82 | 5.71 | 7.54 | ▲ 18.63% | ▲ 47.58% | - | - | - | 33.73% | ▲ 4.80% | 37.59% | ▲ 5.06% | 36.39% | ▲ 4.12% | 7 / 9 | 7,85 | unbegrenzt | 79 / 100 | −3,6 / 100 | −2,59 |
| PharmaEssentia | 77.9 | Arzneimittel (Pharmazeutisch) | Taiwan | 16.7 Mrd. USD | 69.41 | 89.16 | 25.52 | 14.38 | ▲ 94.81% | - | 0.12% | - | - | 32.27% | ▲ 99.91% | 31.52% | ▲ 101.11% | 21.57% | ▲ 90.33% | 6 / 9 | 11,95 | > 50-fach | 37 / 100 | −0,6 / 100 | −2,09 | |
![]() | ACADIA Pharmaceuticals Inc | 77.8 | Arzneimittel (Biotechnologie) | USA | 4.8 Mrd. USD | 12.60 | 27.50 | 4.21 | 3.67 | ▲ 19.39% | - | - | - | - | 36.49% | ▲ 20.77% | 9.78% | ▲ 15.73% | 9.81% | ▲ 11.05% | 6 / 9 | 3,94 | unbegrenzt | 63 / 100 | 18,0 / 100 | −0,81 |
![]() | ALK-Abelló A/S | 77.5 | Arzneimittel (Pharmazeutisch) | Dänemark | 6.7 Mrd. USD | 32.05 | 23.47 | 6.36 | 6.26 | ▲ 12.58% | ▲ 116.79% | 0.82% | - | - | 18.96% | ▲ 3.40% | 26.35% | ▲ 4.71% | 24.41% | ▲ 5.30% | 8 / 9 | 8,12 | 32-fach | 45 / 100 | −6,8 / 100 | −2,92 |
![]() | Argen-X | 77.5 | Arzneimittel (Biotechnologie) | Niederlande | 61.5 Mrd. USD | 25.49 | 54.99 | 8.09 | 7.31 | ▲ 158.22% | - | - | - | - | 32.38% | ▲ 42.91% | 24.82% | ▲ 35.61% | 21.09% | ▲ 54.95% | 6 / 9 | 10,75 | > 50-fach | 43 / 100 | 5,3 / 100 | −1,64 |
| Shanghai Allist Pharmaceuticals Co. Ltd. A | 77.1 | Arzneimittel (Biotechnologie) | China | 6.7 Mrd. USD | 16.76 | 82.22 | 7.32 | 5.29 | ▲ 520.80% | - | 1.21% | - | 1 Jahre | 42.18% | ▲ 10.11% | 49.68% | ▲ 12.09% | 41.31% | ▲ 18.71% | 8 / 9 | 15,25 | > 50-fach | 57 / 100 | −2,3 / 100 | −2,07 | |
| 3SBio Inc | 76.8 | Arzneimittel (Biotechnologie) | China | 4.9 Mrd. USD | 3.98 | 3.52 | 1.85 | 1.19 | ▲ 25.93% | ▲ 58.96% | 1.62% | - | - | 47.93% | ▲ 3.91% | 59.59% | ▲ 6.09% | 51.58% | ▲ 9.66% | 9 / 9 | 12,55 | 33-fach | 49 / 100 | −3,6 / 100 | −2,40 | |
| Sunshine Guojian Pharmaceutical Shanghai Co Ltd | 76.6 | Arzneimittel (Biotechnologie) | China | 5.1 Mrd. USD | 10.94 | 14.47 | 7.71 | 4.01 | ▲ 45.00% | - | 1.24% | - | 1 Jahre | 69.98% | ▲ 18.91% | 78.43% | ▲ 22.26% | 66.45% | ▲ 24.08% | 6 / 9 | 18,28 | > 50-fach | 15 / 100 | 7,1 / 100 | −2,04 | |
| Tianjin Lisheng Pharmaceutical Co Ltd | 76.6 | Arzneimittel (Pharmazeutisch) | China | 0.6 Mrd. USD | 27.09 | 12.47 | 3.20 | 0.93 | ▲ 4.07% | ▲ 117.40% | 8.45% | ▲ 58.74% | - | 30.04% | ▲ 4.34% | 33.75% | ▲ 4.87% | 29.76% | ▲ 1.70% | 8 / 9 | 10,11 | > 50-fach | 25 / 100 | −0,6 / 100 | −2,88 | |
![]() | Bavarian Nordic | 76.6 | Arzneimittel (Biotechnologie) | Dänemark | 2.4 Mrd. USD | 9.98 | 12.44 | 2.45 | 1.17 | ▲ 27.21% | ▲ 37.73% | - | - | - | 22.29% | ▲ 12.19% | 14.92% | ▲ 7.42% | 22.08% | ▲ 23.49% | 8 / 9 | 12,13 | 27-fach | 20 / 100 | −9,0 / 100 | −3,09 |
![]() | Shionogi & Co. Ltd | 76.2 | Arzneimittel (Pharmazeutisch) | Japan | 15.0 Mrd. USD | 8.76 | 11.44 | 4.09 | 1.31 | ▲ 11.09% | ▲ 13.04% | 2.74% | ▲ 5.14% | - | 41.06% | ▲ 0.95% | 32.30% | ▼ -0.04% | 39.85% | ▲ 3.74% | 6 / 9 | 5,75 | 27-fach | 16 / 100 | −0,3 / 100 | −3,05 |
| Tianjin Zhongxin Pharmaceutical Group Corp Ltd | 76.0 | Arzneimittel (Pharmazeutisch) | China | 4.0 Mrd. USD | 31.35 | - | 5.63 | 4.48 | ▼ -5.73% | ▲ 26.35% | 13.87% | - | 1 Jahre | 43.34% | ▲ 8.45% | 19.75% | ▲ 3.77% | 6.96% | ▼ -0.21% | 5 / 9 | 5,91 | > 50-fach | 31 / 100 | 14,3 / 100 | −3,15 | |
| Xiamen Amoytop Biotech Co Ltd | 75.9 | Arzneimittel (Biotechnologie) | China | 3.2 Mrd. USD | 19.56 | - | 5.28 | 6.85 | ▲ 36.01% | ▲ 54.85% | 1.19% | - | 2 Jahre | 28.08% | ▲ 3.47% | 33.92% | ▲ 3.17% | 12.81% | ▲ 1.48% | 7 / 9 | 12,13 | > 50-fach | 86 / 100 | 13,0 / 100 | −1,26 | |
![]() | Kiniksa Pharmaceuticals Ltd | 75.9 | Arzneimittel (Biotechnologie) | Vereinigtes Königreich - UK | 6.0 Mrd. USD | 73.78 | 32.50 | 7.08 | 9.10 | ▲ 144.82% | - | - | - | - | 8.71% | ▲ 74.34% | 11.40% | ▲ 82.03% | 3.75% | ▲ 77.22% | 6 / 9 | 5,18 | unbegrenzt | 48 / 100 | 4,4 / 100 | −2,22 |
![]() | ADMA Biologics Inc | 75.4 | Arzneimittel (Biotechnologie) | USA | 2.1 Mrd. USD | 12.24 | 17.75 | 4.04 | 5.06 | ▲ 64.60% | - | - | - | - | 28.80% | ▲ 32.38% | 37.53% | ▲ 27.74% | 5.45% | ▲ 39.54% | 5 / 9 | 8,78 | 7-fach | 47 / 100 | 15,5 / 100 | −0,22 |
![]() | Gilead Sciences Inc | 75.4 | Arzneimittel (Biotechnologie) | USA | 178.2 Mrd. USD | - | 13.74 | 5.85 | 15.07 | ▲ 3.58% | ▲ 133.35% | 2.27% | ▲ 2.92% | 10 Jahre | 28.90% | ▼ -0.30% | 39.74% | ▼ -1.42% | 32.12% | ▼ -0.97% | 8 / 9 | 3,37 | 7-fach | 39 / 100 | −2,6 / 100 | −2,45 |
| TTY Biopharm Co Ltd | 75.1 | Arzneimittel (Pharmazeutisch) | Taiwan | 0.6 Mrd. USD | 16.72 | 13.34 | 3.99 | 2.77 | ▲ 8.86% | ▲ 11.03% | 5.81% | - | 3 Jahre | 24.16% | ▲ 1.46% | 26.42% | ▼ -0.08% | 24.97% | ▼ -0.33% | 7 / 9 | 6,58 | 49-fach | 35 / 100 | −1,9 / 100 | −2,33 | |
| Jiangsu Nhwa Pharmaceutical Co Ltd | 74.8 | Arzneimittel (Pharmazeutisch) | China | 3.2 Mrd. USD | 19.79 | - | 3.55 | 2.59 | ▲ 11.95% | ▲ 7.73% | 1.87% | ▲ 31.95% | 2 Jahre | 17.89% | ▼ -0.57% | 19.63% | ▼ -0.77% | 10.84% | ▼ -0.77% | 6 / 9 | 13,97 | > 50-fach | 46 / 100 | −0,2 / 100 | −3,30 | |
![]() | Orion Oyj B | 74.7 | Arzneimittel (Pharmazeutisch) | Finnland | 12.8 Mrd. USD | 18.78 | 28.37 | 5.36 | 8.69 | ▲ 11.88% | ▲ 17.87% | 2.28% | - | 3 Jahre | 26.48% | ▲ 1.10% | 33.08% | ▲ 1.36% | 11.60% | ▼ -1.55% | 7 / 9 | 8,48 | > 50-fach | 60 / 100 | 9,1 / 100 | −1,29 |
![]() | Sectra AB (publ) | 74.5 | Arzneimittel (Pharmazeutisch) | Schweden | 5.7 Mrd. USD | 89.02 | 64.91 | 14.74 | 23.73 | ▲ 16.75% | ▲ 15.40% | 0.45% | - | 1 Jahre | 15.92% | ▲ 0.10% | 18.72% | ▼ -0.60% | 28.57% | ▲ 1.18% | 6 / 9 | 5,24 | > 50-fach | 16 / 100 | −11,9 / 100 | −3,41 |
| Beijing Strong Biotechnologies Inc | 74.5 | Arzneimittel (Biotechnologie) | China | 1.0 Mrd. USD | 29.31 | 42.21 | 4.83 | 1.84 | ▲ 9.83% | ▲ 11.08% | 12.00% | - | - | 14.01% | ▼ -1.64% | 35.03% | ▲ 1.05% | 38.79% | ▲ 5.62% | 7 / 9 | 7,73 | 11-fach | 21 / 100 | −7,4 / 100 | −2,93 | |
| Jiangzhong Pharmaceutical Co Ltd | 74.0 | Arzneimittel (Pharmazeutisch) | China | 2.1 Mrd. USD | 16.21 | 286.73 | 3.54 | 3.59 | ▲ 11.56% | ▲ 13.85% | 6.18% | ▲ 16.72% | 3 Jahre | 21.47% | ▲ 1.01% | 24.18% | ▲ 0.87% | 16.36% | ▼ -2.42% | 8 / 9 | 6,25 | > 50-fach | 44 / 100 | −1,0 / 100 | −2,80 | |
![]() | AstraZeneca PLC | 73.8 | Arzneimittel (Pharmazeutisch) | Vereinigtes Königreich - UK | 245.4 Mrd. USD | 23.53 | 29.11 | 4.01 | 4.85 | ▲ 14.95% | ▲ 24.71% | 2.04% | ▲ 4.17% | - | 17.41% | ▲ 3.98% | 23.40% | ▲ 4.39% | 14.76% | ▲ 0.66% | 9 / 9 | 1,82 | 7-fach | 42 / 100 | −3,8 / 100 | −2,45 |
| Wuhan Keqian Biology Co Ltd | 73.7 | Arzneimittel (Biotechnologie) | China | 0.9 Mrd. USD | 18.68 | 125.99 | 6.95 | 1.44 | ▲ 2.42% | ▼ -1.48% | 4.87% | ▲ 17.15% | - | 43.73% | ▼ -1.63% | 50.34% | ▼ -1.92% | 36.27% | ▲ 4.24% | 6 / 9 | 12,62 | > 50-fach | 13 / 100 | −0,2 / 100 | −2,27 |